Revisiting the Debate of ‘Routine’ vs ‘Selective’ Microscopic Evaluation of Cholecystectomies: Observations from an Indian Archipelago on the Incidence of Dysplasia and Incidental Gallbladder Cancer

Authors

  • Seetu Palo Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India
  • Chitrawati Bal Gargade Department of Pathology, BKL Walawalkar Rural Medical College, Sawarde, Maharashtra, India

DOI:

https://doi.org/10.21276/apalm.3448

Keywords:

Cancer, Cholelithiasis, Cholesterolosis, Dysplasia, Gallbladder

Abstract

Background: Gallstone disease or cholelithiasis is a common indication for cholecystectomy globally, with various histopathological alterations in gallbladder mucosa. Understanding these changes is crucial for determining their relationship with gall bladder cancer and justifying histopathological examination policies. In this context, this study was undertaken to investigate the range of histomorphological abnormalities found in gall bladder specimens removed for cholelithiasis. Additionally, the study seeks to establish the prevalence of dysplasia and incidental gall bladder cancer in these specimens.

Materials and Methods: A retrospective study spanning five years was conducted at a tertiary care hospital. Demographic data, macroscopic features, and histopathological findings of all cholecystectomy specimens were recorded and analyzed.

Results: Among 1,380 patients, chronic cholecystitis (75.3%) was most common, followed by cholesterolosis (17.9%) and xanthogranulomatous cholecystitis (1.7%). Only two cases (0.14%) of gallbladder cancer were found. Low-grade dysplasia was present in 0.9% of cases. No cases of incidental gallbladder cancer were encountered.

Conclusion: Chronic cholecystitis predominates in cholecystectomy specimens for cholelithiasis in our setting, with low rates of neoplastic pathology. The absence of incidental gallbladder cancer in the study favors selective over routine histopathological examination. However, further validation studies and cost-benefit analyses are needed to form evidence-based guidelines regarding the policy of selective histopathological examination of resected gallbladder specimens in the Indian setup.

References

1. Jha AK, Ali A, Kumar M, Kumar M, Bhadani PP, Murthy NBS, et al. Outcome of routine histopathological examination of gallbladder specimen following elective laparoscopic cholecystectomy. J Carcinog. 2021;20:19.

2. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver. 2012;6:172–87.

3. Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8:33.

4. Zhu Z, Luo K, Zhang B, Wang G, Guo K, Huang P, et al. Risk factor analysis and construction of prediction models of gallbladder carcinoma in patients with gallstones. Front Oncol. 2023;13:1037194.

5. Savanur K, Dhar R, Sahu S. Study of histopathological spectrum of gallbladder diseases. Int J Med Sci Clin Res Rev. 2022;5:866–71.

6. Degloorkar S, Parab S, Shah B, Prasad S, Gore S. A retrospective single centre study on histopathological analysis of cholecystectomy specimens in a tertiary care centre in India. Int Surg J. 2023;10:1616–20.

7. Kotasthane VD, Kotasthane DS. Histopathological spectrum of gall bladder diseases in cholecystectomy specimens at a rural tertiary hospital of Purvanchal in North India-Does it differ from South India? IP Arch Cytol Histopathol Res. 2020;5:91–5.

8. Beena D, Shetty J, Jose V. Histopathological spectrum of diseases in gallbladder. Natl J Lab Med. 2017;6:PO06–96.

9. Munjal D, Kumar N, Gupta M, Shrivastava RK, Sharma HB. Spectrum of histomorphological lesions of gall bladder in cholecystectomy specimens: A cross-sectional study. Int J Sci Stud. 2023;11:24–9.

10. Mali N, Sunda P, Vyas SP, Saini AK, Rankawat M. A study of spectrum of histopathological lesions in gall bladder in cholecystectomy specimens. Int J Toxicol Pharmacol Res. 2023;13:35–43.

11. Kumar H, Dundy G, Kini H, Tiwari A, Bhardwaj M. Spectrum of gallbladder diseases- A comparative study in North Vs South Indian population. Indian J Pathol Oncol. 2018;5:273–6.

12. Petrushenko VV, Grebeniuk DI, Liakhovchenko NA, Gormash PP. Gallbladder cholesterolosis in patients with metabolic syndrome and chronic pancreatitis. Rep Morphol. 2021;27:58–65.

13. Alaqeel SA, Alaqeel FO, Saleh KA, Al-Mulhim AA. An enigma of the gallbladder. Saudi J Med Med Sci. 2016;4:242–4.

14. Dairi S, Demeusy A, Sill AM, Patel ST, Kowdley GC, Cunningham SC. Implications of gallbladder cholesterolosis and cholesterol polyps? J Surg Res. 2016;200:467–72.

15. Yaylak F, Deger A, Ucar BI, Sonmez Y, Bayhan Z, Yetisir F. Cholesterolosis in routine histopathological examination after cholecystectomy: What should a surgeon behold in the reports? Int J Surg Lond Engl. 2014;12:1187–91.

16. Bolukbasi H, Kara Y. An important gallbladder pathology mimicking gallbladder carcinoma: Xanthogranulomatous cholecystitis: A single tertiary center experience. Surg Laparosc Endosc Percutan Tech. 2020;30:285–9.

17. Makimoto S, Takami T, Hatano K, Kataoka N, Yamaguchi T, Tomita M, et al. Xanthogranulomatous cholecystitis: A review of 31 patients. Surg Endosc. 2021;35:3874–80.

18. De Zoysa MIM, De Silva SKLA, Illeperuma A. Is routine histological examination of gall bladder specimens justifiable? Ceylon Med J. 2010;55:13–6.

19. Darmas B, Mahmud S, Abbas A, Baker AL. Is there any justification for the routine histological examination of straightforward cholecystectomy specimens? Ann R Coll Surg Engl. 2007;89:238–41.

20. Tantia O, Jain M, Khanna S, Sen B. Incidental carcinoma gall bladder during laparoscopic cholecystectomy for symptomatic gall stone disease. Surg Endosc. 2009;23:2041–6.

21. Mittal R, Jesudason MR, Nayak S. Selective histopathology in cholecystectomy for gallstone disease. Indian J Gastroenterol. 2010;29:26–30.

22. Junejo A, Khatoon S, Lal K, Shaikh BF, Yousuf Z. Incidence of carcinoma of gall bladder in patients with cholelithiasis. Med Channel. 2012;18:7–10.

23. Swank HA, Mulder IM, Hop WC, van de Vijver MJ, Lange JF, Bemelman WA. Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: A systematic review. Surg Endosc. 2013;27:4439–48.

24. Alabi A, Arvind AD, Pawa N, Karim S, Smith J. Incidental gallbladder cancer: Routine versus selective histological examination after cholecystectomy. Surg J N Y N. 2021;7:e22–5.

25. Benkhadoura M, Elshaikhy A, Eldruki S, Elfaedy O. Routine histopathological examination of gallbladder specimens after cholecystectomy: Is it time to change the current practice? Turk J Surg. 2019;35:86–90.

26. Olthof PB, Metman MJH, de Krijger RR, Scheepers JJ, Roos D, Dekker JWT. Routine pathology and postoperative follow-up are not cost-effective in cholecystectomy for benign gallbladder disease. World J Surg. 2018;42:3165–70.

27. Paliogiannis P, Scognamillo F, Attene F, Marrosu A, Trignano E, Tedde L, et al. Preneoplastic and neoplastic gallbladder lesions occasionally discovered after elective videocholecystectomy for benign disease. A single centre experience and literature review. Ann Ital Chir. 2013;84:281–5.

28. Agarwal AK, Kalayarasan R, Singh S, Javed A, Sakhuja P. All cholecystectomy specimens must be sent for histopathology to detect inapparent gallbladder cancer. HPB. 2012;14:269–73.

29. Shrestha R, Tiwari M, Ranabhat SK, Aryal G, Rauniyar SK, Shrestha HG. Incidental gallbladder carcinoma: Value of routine histological examination of cholecystectomy specimens. Nepal Med Coll J. 2010;12:90–4.

30. Waghmare RS, Kamat RN. Incidental gall bladder carcinoma in patients undergoing cholecystectomy: A report of 7 cases. J Assoc Physicians India. 2014;62:793–6.

31. Bastiaenen VP, Tuijp JE, van Dieren S, Besselink MG, van Gulik TM, Koens L, et al. Safe, selective histopathological examination of gallbladder specimens: A systematic review. Br J Surg. 2020;107:1414–28.

32. Corten BJGA, Leclercq WKG, Dejong CH, Roumen RMH, Slooter GD. Selective histological examination after cholecystectomy: An analysis of current daily practice in the Netherlands. World J Surg. 2019;43:2561–70.

33. Corten BJGA, van Kuijk SMJ, Leclercq WKG, Janssen L, Roumen RMH, Dejong CHC, et al. A Dutch prediction tool to assess the risk of incidental gallbladder cancers after cholecystectomies for benign gallstone disease. HPB. 2023;25:409–16.

34. Choi KS, Choi SB, Park P, Kim WB, Choi SY. Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: A systematic review and meta-analysis. World J Gastroenterol WJG. 2015;21:1315.

35. Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg. 2019;106:32–45.

Downloads

Published

31-12-2024

How to Cite

1.
Palo S, Gargade CB. Revisiting the Debate of ‘Routine’ vs ‘Selective’ Microscopic Evaluation of Cholecystectomies: Observations from an Indian Archipelago on the Incidence of Dysplasia and Incidental Gallbladder Cancer. Ann of Pathol and Lab Med [Internet]. 2024 Dec. 31 [cited 2025 Jan. 15];11(12):A360-368. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3448

Issue

Section

Original Article